1. Homepage
  2. Equities
  3. China
  4. Shanghai Stock Exchange
  5. Jointown Pharmaceutical Group Co., Ltd
  6. News
  7. Sector news
    600998   CNE100000W45

JOINTOWN PHARMACEUTICAL GROUP CO., LTD

(600998)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news
Sector news Other Pharmaceuticals
07:11aLegend Biotech Receives Conditional European Commission Approval for Multiple Myeloma D..
MT
05:54aROCHE HOLDINGS AG : Deutsche Bank reaffirms its Neutral rating
MD
03:42aROCHE HOLDINGS AG : Bernstein reaffirms its Buy rating
MD
12:49aUK Competition Watchdog Prepares For Supreme Court Order To Cover Pfizer, Flynn Pharma'..
MT
05/25Eli Lilly to Spend $2.1 Billion on Two New Manufacturing Facilities in US
MT
05/25INSIDER SELL : Abbvie
MT
05/25Eli Lilly and Company to Expand Manufacturing Sites in Indiana
MT
05/25Lilly to Invest $2.1 Billion in New Manufacturing Sites in Indiana
DJ
05/25Roche's Polivy Receives EU Approval for Lymphoma Treatment
MT
05/25Roche develops test kits to detect monkeypox virus
RE
05/25Roche Develops PCR Tests to Detect Monkeypox Virus
DJ
05/25CORRECTION : Roche Develops PCR Tests for Monkeypox Virus Research
MT
05/25Roche Develops PCR Tests for Monkeypox Virus Research
MT
05/25Roche develops test kits to detect monkeypox virus
RE
05/25PFIZER INC : Goldman Sachs reiterates its Neutral rating
MD
05/25Teva Pharmaceutical Settles Opioid Suit With West Virginia
DJ
05/25Pfizer Launches Initiative to Sell Medicines, Vaccines to 45 Low-Income Countries on a ..
MT
05/25Pfizer to Make Patented Treatments Available at Cost in Lower-Income Countries
MT
05/24TRANSCRIPT : Pfizer Inc. - Special Call
CI
05/24TRANSCRIPT : Johnson & Johnson Presents at UBS Global Healthcare Conference, May-24-2022 1..
CI
05/24TRANSCRIPT : Eli Lilly and Company Presents at UBS Global Healthcare Conference, May-24-20..
CI
05/24Pfizer Inc. Presents ELEVATE Pivotal Findings Demonstrating Etrasimod’s Potentiall..
CI
05/24Pfizer Sees Positive Results in Etrasimod Trials
DJ
05/24Eli Lilly and Company Announces Updates on Lilly's Pivotal Phase 3 Study
CI
05/23Roche Secures Exclusive Licensing Deal For KaliVir's Novel Oncolytic Vaccinia Viruses
MT
05/23Bayer's Xarelto Shows Long-Term Effect in Heart Disease Patients
MT
05/23What you need to know about the coronavirus right now
RE
05/23AbbVie Presents Positive Data from Phase 3 Study of Cariprazine (VRAYLAR®) for Adjuncti..
CI
05/23Pfizer, BioNTech Say Third Dose of COVID-19 Vaccine About 80% Effective in Children Age..
MT
05/23Pfizer, BioNTech Publish Data Supporting COVID-19 Vaccine Efficacy In Children Aged Six..
MT
05/23SVB Securities Initiates Eli Lilly and Co. at Outperform With $341 Price Target
MT
05/23SVB Securities Initiates AbbVie at Underperform With $140 Price Target
MT
05/23Pfizer-BioNTech COVID-19 Vaccine Demonstrates Strong Immune Response, High Efficacy and..
CI
05/23ANALYST RECOMMANDATIONS : AbbVie, Amgen, Caterpillar, HP, Nike...
05/23AbbVie Says EMA Committee Backs Approval of Bowel Disease Drug Candidate
MT
05/23AbbVie Inc. Announces CHMP Recommended European Commission Approval of Upadacitinib (RI..
CI
05/20Wall Street ends mixed after punishing week
RE
05/20DOJ Objects to Cost of J&J Talc Unit Hiring Katyal For Appeal
DJ
05/20Top Midday Gainers
MT
05/20Rite Aid to Start Administering Pfizer's Booster Shot to Chidren Ages 5 to 11
MT
05/20Pfizer Enters Deal to Sell COVID-19 Drug Paxlovid to Switzerland
MT
05/20Pfizer's Xeljanz Recommended By European Medicines Agency Committee to Treat Ankylosing..
MT
05/20Switzerland Secures Order for Pfizer's Antiviral COVID-19 Drug Paxlovid
MT
05/20Immix Biopharma Says Cancer Drug IMX-110 Showed Higher Survival Rate Versus Johnson & J..
MT
05/20Berenberg Bank Adjusts AbbVie's Price Target to $135 From $115, Maintains Hold Rating
MT
05/20Eli Lilly, Incyte Say EMA Committee Recommends Approval of Alopecia Areata Drug Candida..
MT
05/20AbbVie Says It Has Filed New Drug Application With FDA for Advanced Parkinson's Disease..
MT
05/20AbbVie Submits New Drug Application to U.S. FDA for Investigational ABBV-951 (Foscarbid..
CI
05/20Lilly and Incyte's Olumiant Gets CHMP Recommendation in Alopecia Areata
DJ
05/20AbbVie Seeks FDA OK for ABBV-951 in Advanced Parkinson's Disease
DJ
1  2  3  4  5  6  7  8  9  10Next
Upcoming event on JOINTOWN PHARMACEUTICAL GROUP CO., LTD